Filing Details
- Accession Number:
- 0001179110-17-011954
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-09-01 17:09:36
- Reporting Period:
- 2017-08-30
- Accepted Time:
- 2017-09-01 16:09:36
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
815094 | Abiomed Inc | ABMD | Surgical & Medical Instruments & Apparatus (3841) | 042743260 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1139301 | Md A Eric Rose | C/O Abiomed, Inc. 22 Cherry Hill Drive Danvers MA 01923 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock, $.01 Par Value | Acquisiton | 2017-08-30 | 982 | $7.67 | 13,634 | No | 4 | M | Direct | |
Common Stock, $.01 Par Value | Disposition | 2017-08-30 | 982 | $145.17 | 12,652 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (right to buy) | Disposition | 2017-08-30 | 982 | $0.00 | 12,000 | $7.67 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | 2010-08-12 | 2019-08-12 | No | 4 | M | Direct |
Footnotes
- Grant to reporting person of option to buy shares of Common Stock set forth in Table II, Column 7, under the ABIOMED, Inc. 2008 Stock Incentive Plan.
- This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $145.0000 and $145.4300. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.